PYXIS ONCOLOGY INC. - COMMON STOCK
4.1500
17-May-24 15:59:57
15 minutes delayed
Stocks
-0.0200
-0.48%
Today's range
4.1000 - 4.2700
ISIN
N/A
Source
NASDAQ
-
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
14 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
09 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
27 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
13 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
07 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
05 Mar 2024 16:45:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Announces $50 Million Private Placement
27 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Dec 2023 16:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
28 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
07 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 09:18:58 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Participate in Two Upcoming Investment Conferences
31 Aug 2023 16:01:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Successfully Completes Acquisition of Apexigen
23 Aug 2023 08:35:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
11 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 Jun 2023 17:00:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs
30 May 2023 08:30:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology to Acquire Apexigen
24 May 2023 06:45:00 By Nasdaq GlobeNewswire
-
Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
11 May 2023 07:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >